# Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.

> **NCT04564521** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Retinoblastoma

## Interventions

- **DRUG:** Nitroglycerin
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT04564521
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-28
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04564521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04564521, "Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04564521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*